Home The New Strategic CDMO: End-to-End Solutions for Better and Faster Drug Development
 

Keywords :   


The New Strategic CDMO: End-to-End Solutions for Better and Faster Drug Development

2016-05-17 11:52:14| drugdiscoveryonline News Articles

While Big Pharma historically has kept development activities and CMC management in-house, unpredictable pipelines and increasing drug complexity have compelled the industry to look more seriously at outsourcing drug development and manufacturing to increase productivity and throughput. Bill Weiser, the executive director and global head of analytical sciences at Patheon, discusses how a new generation of CDMOs have positioned themselves to provide more strategic solutions that not only complement product development but also drive therapies to patients faster.

Tags: development solutions drug faster

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11 SGY-PM910ZW
25.11Pioneer DJ DDJ-SP1 DJ
25.11Dr.STONE
25.11
25.1146 dvd
25.11 SONY 4 CUH-1100A
25.11 COMPLETE DVD-BOX6
25.11DAHON /(330mm8°)
More »